Rep. C. Scott Franklin Sells Off Shares of Kenvue Inc. (NYSE:KVUE)

Representative C. Scott Franklin (R-Florida) recently sold shares of Kenvue Inc. NYSE: KVUE. In a filing disclosed on July 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on June 16th. The trade occurred in the Representative's "FIDELITY JOINT TBE" account.

Representative C. Scott Franklin also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Visa NYSE: V on 6/16/2025.
• Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 6/16/2025.
• Sold $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 6/16/2025.
• Sold $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 6/16/2025.
• Sold $15,001 - $50,000 in shares of McDonald's NYSE: MCD on 6/16/2025.
• Sold $1,001 - $15,000 in shares of United Parcel Service NYSE: UPS on 6/16/2025.
• Sold $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 6/16/2025.
• Sold $15,001 - $50,000 in shares of Walmart NYSE: WMT on 6/16/2025.
• Sold $15,001 - $50,000 in shares of Berkshire Hathaway NYSE: BRK.B on 6/16/2025.
• Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 6/16/2025.

Kenvue Stock Up 0.7%

Kenvue stock traded up $0.15 during midday trading on Friday, hitting $22.00. 12,727,162 shares of the company were exchanged, compared to its average volume of 16,312,363. The company has a market cap of $42.21 billion, a PE ratio of 20.00, a price-to-earnings-growth ratio of 3.43 and a beta of 0.83. Kenvue Inc. has a fifty-two week low of $17.85 and a fifty-two week high of $25.17. The company's fifty day moving average price is $22.15 and its 200-day moving average price is $22.30. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The firm had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. During the same quarter in the prior year, the business posted $0.28 earnings per share. Kenvue's revenue for the quarter was down 3.9% on a year-over-year basis. On average, research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on KVUE shares. Citigroup cut their target price on Kenvue from $24.50 to $22.00 and set a "neutral" rating on the stock in a research note on Tuesday. UBS Group cut their price objective on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday. Evercore ISI assumed coverage on shares of Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 target price for the company. Bank of America dropped their price target on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Tuesday. Finally, Barclays cut their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Kenvue has an average rating of "Hold" and an average price target of $24.71.

Institutional Trading of Kenvue

Several large investors have recently added to or reduced their stakes in the company. First Pacific Financial purchased a new position in shares of Kenvue during the 2nd quarter valued at $54,000. Trust Co. of Vermont boosted its position in Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company's stock valued at $33,000 after purchasing an additional 1,150 shares during the last quarter. PFG Investments LLC grew its stake in Kenvue by 39.3% in the second quarter. PFG Investments LLC now owns 18,238 shares of the company's stock valued at $382,000 after purchasing an additional 5,149 shares in the last quarter. LBP AM SA purchased a new position in Kenvue in the second quarter valued at about $6,825,000. Finally, Alley Investment Management Company LLC increased its position in Kenvue by 3.3% in the 2nd quarter. Alley Investment Management Company LLC now owns 272,358 shares of the company's stock worth $5,700,000 after purchasing an additional 8,789 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

About Representative Franklin

Scott Franklin (Republican Party) is a member of the U.S. House, representing Florida's 18th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Franklin (Republican Party) is running for re-election to the U.S. House to represent Florida's 18th Congressional District. He declared candidacy for the 2026 election. Scott Franklin was born in Thomaston, Georgia. Franklin graduated from Lakeland High School. He served in the U.S. Navy from 1986 to 2000 and the U.S. Navy Reserve from 2000 to 2012. Franklin earned a B.S. from the United States Naval Academy in 1986 and an M.B.A. from Embry-Riddle Aeronautical University in 1994. Franklin's career experience includes owning an insurance agency and working as a naval aviator with the U.S. Navy.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.